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Abstract
We propose a novel Bayesian model selection technique on linear mixed-effects mod-
els to compare multiple treatments with a control. A fully Bayesian approach is imple-
mented to estimate the marginal inclusion probabilities that provide a direct measure
of the difference between treatments and the control, along with the model-averaged
posterior distributions. Default priors are proposed for model selection incorporating
domain knowledge and a component-wise Gibbs sampler is developed for efficient pos-
terior computation. We demonstrate the proposed method based on simulated data
and an experimental dataset from a longitudinal study of mouse lifespan and weight
trajectories.
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1 Introduction
Experiments are run by researchers in biology, medicine, and various other scientific fields,
to compare multiple treatments with a control or standard treatment. Often these studies
are conducted over a period of time and result in unbalanced repeated measured data that
is commonly analyzed by the linear mixed-effects model (LMM). The LMM allows for some
subsets of the regression parameters to vary among subjects, thereby accounting for sources
of natural heterogeneity in the population. It models the mean response as a combination
of population characteristics (fixed-effects) that are assumed to be shared by subjects, and
subject-specific characteristics (random-effects) that are unique to a particular subject.
It is common to introduce a set of fixed-effects for each group to model the effect of the
treatment (see e.g. Fitzmaurice et al., 2004). To compare treatment groups with the control
groups is, therefore, equivalent to comparing the sets of fixed-effects. Researchers are often
interested in deciding which treatments are different from the control, and measuring the
corresponding significance of the discrepancy.
Standard model selection procedures can be implemented to answer these questions
(see e.g. Bolker et al., 2009; Fitzmaurice et al., 2004) with certain limitations. One can
select models by using hypothesis tests (Stephens et al., 2005); that is, test simpler nested
models against more complex models and report corresponding p-values. Although the
likelihood ratio test (LRT) is widely used to determine the contribution of a factor in
a model throughout statistics, it is not recommended by Pinheiro and Bates (2006) for
testing fixed-effects in LMM, because of its unreliability for small to moderate sample
size. Also, when the focus is to compare multiple treatments to a control, Burnham and
Anderson (2002) criticize that such a pairwise comparison as an abuse of hypothesis testing.
Another extensively used approach is the information-theoretic model selection procedure
that allows comparison of multiple models (see e.g. Burnham and Anderson, 2002). This
method relies on information criteria, such as Akaike information criterion and Bayesian
information criterion (BIC), that use deviance as a measure of fit with a penalization on
more complex models. Instead of reporting p-values, it estimates the magnitude of difference
between models in expected predictive power and uses this to make a decision as to whether a
variable should be included in the model or not. The resulting dichotomous decisions overly
simplify the problem, and, in our case, withhold important information on the magnitude
of the difference between a treatment and the control.
Motivated by these practical challenges faced by frequentist approaches, we resort to
Bayesian model selection techniques (for a review see e.g. Clyde and George, 2004; George
and McCulloch, 1997; Kuo and Mallick, 1998). In the Bayesian framework, this problem
can be transformed to the form of parameter estimation (O’Hara et al., 2009). That is,
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estimating the marginal posterior probability that a variable should be in the model, i.e. the
marginal inclusion probability, which can usually be calculated directly from the posterior
inference using an Markov chain Monte Carlo (MCMC) simulation.
There is an extensive literature on Bayesian model selection. George and McCulloch
(1993); Geweke et al. (1996) develop the stochastic search variable selection (SSVS) tech-
nique for linear regression models that uses a Gibbs sampler to traverse the model space.
Smith and Kohn (1996) extend its application to nonparametric regression models and show
how integrating the regression parameters is essential to reliable convergence of a Gibbs sam-
pler. Kohn et al. (2001) propose a more efficient single-site Metropolis-Hastings sampler.
Holmes et al. (2002) consider selection and smoothing for a series of seemingly unrelated
regressions. Chen and Dunson (2003); Kinney and Dunson (2007) develop variable selection
for both fixed and random effects in generalized LMM. Recently, Bayesian model selection
methods are extended to a series of spatially linked regression for functional magnetic reso-
nance imaging analysis (see e.g. Lee et al., 2014; Smith and Fahrmeir, 2007). However, we
are unaware of any work to extend Bayesian model selection on LMM to compare multiple
treatments with a baseline.
In this article, we develop a novel Bayesian model selection approach on LMM that ac-
commodates and compares multiple treatment effects. The method includes a re-parameterization
of the fixed-effects of each treatment that attributes part of the effect to a baseline for di-
rect measure of the difference between a treatment and the control. A modification of
the fractional prior (Smith and Kohn, 1997) is proposed to undertake model selection and
averaging, which is also related to Zellner’s g-prior (Zellner, 1986). The proposed prior
incorporates information on subjects within the same group, which is critical to developing
an efficient component-wise Gibbs sampler. This Bayesian paradigm provides practitioners
with an intuitive understanding of the significance of each treatment through the marginal
inclusion probability, which is unaccessible using existing techniques.
Our work is motivated by a longitudinal experiment of mouse lifespan and weight tra-
jectories (see e.g. Spindler et al., 2014a,b, 2013a,b, 2014c) that aims to study how different
treatments affect lifetime weight trajectories and identify potential longevity therapeutics.
This application provides both a clear demonstration of our approach, and an example of
enabling researchers to obtain previously unavailable information. However, the method
itself is more general and applicable to most experiments that are interested in comparing
multiple treatments to a control.
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1.1 Experimental Data
The experimental data is from a longitudinal study of the lifespan and the weight trajectories
of an F1 hybrid mouse (see e.g. Spindler et al., 2014a,b, 2013a,b, 2014c). The study is part
of a compound screening program designed to identify potential longevity therapeutics, and
it was approved by the Institutional Animal Care and Use Committee at the University of
California, Riverside. It utilized an unbalanced statistical design to compare the lifespan
and the weight trajectories of multiple treatment groups to that of one larger control group
(Jeske et al., 2014). The disposition of dietary calories between body weight and metabolic
energy appears to be a key to lifespan determination. In this article, we use a part of the
dataset that recorded mouse body weight changes during the course of the experiment.
In the study, 2266 male C3B6F1 mice were initially fed a chow diet ad libitum. At 12
months of age (Day 365), 297 mice were shifted to daily feeding with 13.3 kcal/day/mouse
of the control diet (Diet No.99), and the rest were shifted to control diet supplemented with
one of 56 chemical, pharmaceutical, or nutraceuticals agents or combination of agents. All
mice were fed daily and weighted bimonthly, but the number of mice progressively declined
as the study progressed due to the onset of various age-related pathologies. The data are
censored at extreme old age (Day 1369), when less than 1% of the mice remained.
The control and drug-treated mice gradually lost weight after the shift to the defined
diets, which provided about 10% less than the ad libitum number of calories, to ensure the
mice consumed all their food. Our main interest is to determine which supplemented diets
significantly affected the lifetime weight trajectories. That is, researchers are interested in
whether any deviation from the trajectory of the control group (Diet No.99) is statistically
significant and is caused by dietary additions.
The rest of the paper is organized as follows. Section 2 formally introduces the Bayesian
variable selection methodology. It outlines the re-parameterization of a LMM, prior speci-
fication, MCMC sampling schemes, and stopping criterion utilized. A simulation study is
also detailed to evaluate the performance of the proposed method. Section 3 contains the
empirical results from the analysis of the motivating example. Section 4 concludes with a
discussion.
2 Model Selection on Linear Mixed-effects Models
In general, suppose that we have n subjects from G experimental groups under study, each
with ni observations taken repeatedly over time, i = 1, · · · , n, and let y i = (yi,1, · · · , yi,ni)T
denote the response vector for the i-th subject. Assume the i-th subject is from the g-th
4
group, for i = 1, · · · , n, g = 1, · · · , G, let Xi and Zi be two ni × p design matrices, then a
LMM (Fitzmaurice et al., 2004; McCullagh and Nelder, 1989) is denoted as
y i = Xiαg + Zibi + i, i ∼ Nni(0, σ2I), (1)
where αg = (αg,0, · · · , αg,p−1)T are the fixed effects shared by subjects in the g-th experi-
mental group. Further, denote bi = (bi,0, · · · , bi,p−1)T ∼ Np(0, λ−1D I) as the random effects
that are unique to the i-th subject, and hence we allow subject specific trajectories.
Note that, among the G groups, there is one control group and G− 1 treatment groups.
Without loss of generality, let us assume the G-th group is the control group, and g =
1, · · · , G−1 are the treatment groups. A primary goal for many experiments is to determine
which alternative treatments significantly differ from the control group. To this end, we
propose a re-parameterization of the fixed effects αg’s in (1), g = 1, · · ·G. Let Wi, Xi and Zi
be three ni × p design matrices, the re-parameterized model is denoted as, for i = 1, · · · , n,
g = 1, · · · , G,
y i = Wiα +Xiβg + Zibi + i, i ∼ Nni(0, σ2I), (2)
where bi = (bi,0, · · · , bi,p−1)T ∼ Np(0, λ−1D I) are the random effects as in (1), and α =
(α0, · · · , αp−1)T are the fixed effects of the control group, βg = (βg,0, · · · , βg,p−1)T are the
fixed effects modeling the difference between the g-th group and the control group. That
is, the group effect αg in (1) is re-written as α + βg in (2), for g = 1, · · · , G. Also, it is
straightforward to see, as the baseline, βG = (0, · · · , 0)T for the control group.
Under the re-parameterization, the detection of significant treatments is equivalent to
the identification of nonzero βg’s. To this end, we introduce 0/1 binary indicators γg =
(γg,0, · · · , γg,p−1)T , g = 1, · · · , G, such that βg,j = 0 if γg,j = 0 and βg,j 6= 0 if γg,j = 1.
The γg,j is used to indicate whether the fixed effect on the j-th predictor of the g-th group
differs from that fixed effect of the control group. Given γg, let βg(γg) be the vector of
nonzero fixed effects and Xi(γg) be the corresponding design matrix. Then, the model (2)
can be written as, for i = 1, · · · , n, g = 1, · · · , G,
y i = Wiα +Xi(γg)βg(γg) + Zibi + i. (3)
This formulation allows us to look at the problem from the Bayesian SSVS perspective
(George and McCulloch, 1993). The SSVS searches for models having high posterior prob-
ability by traversing the model space using MCMC techniques, and, thus, identifies subsets
of predictors with nonzero coefficients. Moreover, it allows us to calculate the posterior
distributions of the parameters by marginalizing over the other variables. In this way, the
marginal inclusion probability can be obtained as a direct measure of the significance of
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each treatment.
Note that, (3) is a very general setting that is applicable to a wide range of applications.
It is possible to impose specific structures on γ to suit different scenarios to further simplify
the modeling procedure. For example, given the setups of the motivating experiment, it is
reasonable to assume a common intercept for all groups, since the mice were on the same
diet at the first measurement; that is, βg,0 = 0, for g = 1, · · · , G. Therefore, given that
the primary goal is to compare treatment groups to the baseline group G, it is desirable to
impose the following settings on γ,
γ1,0 = · · · = γG−1,0 = γG,0 = 0,
γG = (γG,0, · · · , γG,p−1)T = (0, · · · , 0)T .
2.1 Prior Specification
A proper prior must be placed on the nonzero coefficients βg(γg) to undertake model aver-
aging (see e.g. George and McCulloch, 1993; Kohn et al., 2001; Mitchell and Beauchamp,
1988; Smith and Kohn, 1996). In particular, Kohn et al. (2001); Smith and Fahrmeir
(2007) propose a conditional prior for the coefficients by setting it proportional to a frac-
tion of the likelihood. This fractional prior is related to the g-prior in Zellner (1986),
and is located and scaled in line with the information from the likelihood. We propose
a modification of this idea to accommodate multiple subjects within a group by setting
pi
(
βg(γg)|y,α,γg, b, σ2
) ∝ Πi∈g p (y i|α,βg(γg), γg, bi, σ2)1/ni , so that
βg(γg)|y,α,γg, b, σ2 ∼ N
βˆg(γg), σ2
∑
i∈g
1
ni
XTi (γg)Xi(γg)
−1 , (4)
where βˆg(γg) =
(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1 (∑
i∈g
1
ni
XTi (γg) (y i −Wiα − Zibi)
)
, and
∑
i∈g
stands for summation over all the subjects that belong to the g-th group.
This prior is proportional to the variance of the least squares estimate of β, and enjoys
a number of attractive properties as pointed out by Kohn et al. (2001). The prior (4)
is rescaled automatically if the design matrix X or the data y is rescaled because of its
structure and the presence of σ2. Moreover, this prior is invariant to location changes in X
and y given the basis term (1, · · · , 1)T is included in X. Also it is data-based since βˆg(γg)
depends on y, which allows proper centering of β.
We consider the prior on γ to be pi(γg|pig) =
∏p−1
j=0 pi(γg,j |pig), g = 1, · · · , G, where
pi(γg,j |pig) ∼ Bernoulli(pig) and pi = (pi1, · · · , piG)T is a vector of hyper-parameters that
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represents prior knowledge for every groups. Intuitively, pig is the probability that re-
searchers believe the g-th group is significantly different from the control group before
conducting the experiment. For instance, we find a sensible setting, when there is little
prior knowledge of the effects of the treatments, to be letting piG = 0 for the control group,
and pi1 = · · · = piG−1 = 0.5 for the G− 1 treatment groups. We assume standard priors in
Bayesian hierarchical models (see e.g. Gelman et al., 2004; Johnson and Jones, 2010; Smith
and Kohn, 1996) for the rest of the parameters, i.e. α, b, λD, σ
2,
α|d3, d4 ∼ Np(d3, d−14 )
bi|λD ∼ Np(0, λ−1D I), i = 1, · · · , n
λD|d1, d2 ∼ Γ(d1, d2)
pi(σ2) ∝ 1/σ2
where d1, d2, d3, d4 are hyper-parameters to be specified.
2.2 Posterior Inference
Combining the priors and likelihoods, the full joint posterior density for θ = (α, β, γ, b, σ2, λD)
is characterized by
q(α, β, γ, b, σ2, λD|y) ∝
 G∏
g=1
∏
i∈g
p
(
y i|α,βg, γg, bi, σ2
)
pi (bi|λD)
pi (βg|α,γg, b, σ2)pi (γg)

× pi(α)pi(λD)pi(σ2).
(5)
This distribution has a complex form which we cannot sample from directly; instead,
we resort to MCMC methodology for the posterior inference and employ a component-wise
strategy (Johnson et al., 2013). Specifically, we propose a component-wise Gibbs sampler
for posterior computation. To this end, we need the full conditional posterior distributions
of each of the parameters in θ to update the Markov chain. The derivation of the full
conditional posterior distributions follows from (5) using straightforward algebraic route.
Schematically, we can set up a six-variable component-wise Gibbs sampler; that is, if we
let θ = (γ, β,α, σ2, b, λD) be the current state and θ
′ = (γ′, β′,α′, (σ2)′, b′, λ′D) be the future
state, we iteratively sample from the full conditional posterior distributions to update the
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chain,
(γ, β,α, σ2, b, λD)→ (γ′, β,α, σ2, b, λD)→ (γ′, β′,α, σ2, b, λD)→ (γ′, β′,α′, σ2, b, λD)
→ (γ′, β′,α′, (σ2)′, b, λD)→ (γ′, β′,α′, (σ2)′, b′, λD)→ (γ′, β′,α′, (σ2)′, b′, λ′D).
Step 1. The transition γ → γ′ consists of G× p steps,
(γ1,0, γ1,1, · · · , γ1,p−1, · · · , γG,0, · · · , γG,p−1)→ (γ′1,0, γ1,1, · · · , γ1,p−1, · · · , γG,0, · · · , γG,p−1)
→ (γ′1,0, γ′1,1, · · · , γ1,p−1, · · · , γG,0, · · · , γG,p−1)
...
→ (γ′1,0, γ′1,1, · · · , γ′1,p−1, · · · , γ′G,0, · · · , γ′G,p−1).
From the Appendix, we have, for g = 1, · · · , G and j = 0, · · · , p− 1,
q(γg,j |α,γ−(g,j), b, σ2, y) ∝ piγg,jg (1− pig)1−γg,j
( |∑i∈g 1niXTi (γg)Xi(γg)|
|∑i∈g(1 + 1ni )XTi (γg)Xi(γg)|
) 1
2
× exp
{
− 1
2σ2
[∑
i∈g
φTi φ +
(∑
i∈g
1
ni
XTi (γg)φi
)T(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)φi
)
−
(∑
i∈g
(1 +
1
ni
)XTi (γg)φi
)T(∑
i∈g
(1 +
1
ni
)XTi (γg)Xi(γg)
)−1(∑
i∈g
(1 +
1
ni
)XTi (γg)φi
)]}
,
(6)
where γ−(g,j) = (γg,0, · · · , γg,j−1, γg,j+1, · · · , γg,p−1)T and φi = y i −Wiα − Zibi.
At each step, an update is simulated from γg,j
′ ∼ q(γg,j |α,γ−(g,j), b, σ2, y). Since γg,j is
binary, i.e. γg,j ∈ {0, 1}, the conditional posterior distribution q(γg,j |α,γ−(g,j), b, σ2, y)
is easily normalized by evaluating (6) for γg,j = 0 and γg,j = 1.
Step 2. The transition β → β′ consists of G steps,
(β1,β2, · · · ,βG)→ (β1′,β2, · · · ,βG)
→ (β1′,β2′, · · · ,βG)
...
→ (β1′,β2′, · · · ,βG′).
At each step, an update is simulated from a p-dimensional multivariate normal dis-
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tribution,
βg
′(γg) ∼ q(βg(γg)|α,γg, b, σ2, y)
∼ N∑p−1
j=0 γg,j
V −11
 1
σ2
∑
i∈g
XTi (γg)(y i −Wiα − Zibi)
 , V −11
 , (7)
where V1 =
1
σ2
∑
i∈g(1 +
1
ni
)XTi (γg)Xi(γg).
Step 3. Consider updating α where the update is simulated from a p-dimensional multivariate
normal distribution,
α′ ∼ q(α|β, γ, b, σ2, y)
∼ Np
(
V −12
[
1
σ2
G∑
g=1
(∑
i∈g
W Ti
(
y i −Xi(γg)βg(γg)− Zibi
)
+
(∑
i∈g
1
ni
XTi (γg)Wi
)T(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)(y i −Xi(γg)βg(γg)− Zibi)
))
+ d4d3
]
, V −12
)
,
(8)
where
V2 =
1
σ2
G∑
g=1
[∑
i∈g
W Ti Wi+
(∑
i∈g
1
ni
XTi (γg)Wi
)T(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)Wi
)]
+d4.
Step 4. Consider updating σ2. At each step, an update is simulated from a Inverse-Gamma
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distribution,
(σ2)′ ∼ q(σ2|α, β, γ, b, y)
∼ Inv-Gamma
(
1
2
(N +
G∑
g=1
p−1∑
j=0
γg,j),
1
2
G∑
g=1
[∑
i∈g
(
y i −Wiα −Xi(γg)βg(γg)− Zibi
)T(
y i −Wiα −Xi(γg)βg(γg)− Zibi
)
+
[
βg −
(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)φi
)]T(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1
[
βg −
(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)φi
)]])
,
(9)
whereN =
∑G
g=1
∑
i∈g ni. Note that, we denote Inv-Gamma(α, β) =
βα
Γ(α)x
−α−1 exp
(
−β
x
)
,
for x ∈ (0,∞), and α, β > 0.
Step 5. The transition b→ b′ consists of n steps,
(b1, b2, · · · , bn)→ (b1′, b2, · · · , bn)
→ (b1′, b2′, · · · , bn)
...
→ (b1′, b2′, · · · , bn′).
At each step, assuming the i-th subject is from the g-th group, an update is simulated
from a p-dimensional multivariate normal distribution,
bi
′ ∼ q(bi|α,βg, γg, σ2, λD, y i)
∼ Np
(
V −13
1
σ2
[
1
ni
ZTi Xi(γg)
(∑
j∈g
1
nj
XTj (γg)Xj(γg)
)−1(∑
j∈g
j 6=i
1
nj
XTj (γg)φj +
1
ni
XTi (γg)φi
)
+ ZTi
(
y i −Wiα − (1 + 1
ni
)Xi(γg)βg(γg)
)]
, V −13
)
,
(10)
where V3 =
1
σ2
ZTi Zi + λDI +
1
σ2
1
ni
ZTi Xi(γg)
(∑
j∈g
1
nj
XTj (γg)Xj(γg)
)−1
XTi (γg)Zi.
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Step 6. Finally, consider updating λD. At each step, an update is simulated from a Gamma
distribution,
λD
′ ∼ q(λD|b)
∼ Γ(np
2
+ d1,
1
2
G∑
g=1
∑
i∈g
bTi bi + d2).
(11)
The posterior inference on model parameters can be carried out using the MCMC sam-
ples. Models with high posterior probability can be identified as those appearing most often
in the MCMC output. One posterior quantity of interest is the marginal inclusion proba-
bility, i.e. Pr(γg,j = 1|y), g = 1, · · · , G, j = 0, · · · , p− 1, which can be calculated using the
proportion of draws in which γg,j is non-zero. It provides a direct measure of the signifi-
cance of βg,j , which remains challenging for the current frequentist methods. It, therefore,
allows researchers for straightforward understanding of the significance of each treatment.
Also, if needed, one may classify a treatment effect such that Pr(γg,j = 1|y) > 0.8772 as
significant or otherwise insignificant (see e.g. Lee et al., 2014; Raftery et al., 1996; Smith
and Fahrmeir, 2007).
2.3 Stopping Criterion
Determining how long to run an MCMC simulation is critical to performing legitimate pos-
terior inference. Premature termination often runs the risk of getting inaccurate estimates.
The relative standard deviation fixed-width stopping rule (FWSR) (see e.g. Flegal and
Gong, 2015; Gong and Flegal, 2015) is implemented to terminate the MCMC simulation.
It is a member of the FWSR family (for e.g. see Flegal and Gong, 2015; Flegal et al., 2008;
Jones et al., 2006). The relative standard deviation FWSR is theoretically valid in that it
terminates a simulation w.p. 1 and the resulting confidence interval achieves the nominal
coverage probability. Moreover, it automates the stopping procedure for practitioners and
outperforms convergence diagnostics in various numerical studies. Interested readers are
directed to their papers for more details.
In short, the relative standard deviation FWSR terminates the simulation when the
computational uncertainty is relatively small to the posterior uncertainty. Specifically, it
controls the width of a confidence interval from a Markov chain central limit theorem
through a threshold  and significant level δ. Gong and Flegal (2015) also establish a
connection between the standard deviation FWSR and using effective sample size (ESS)
as a stopping criteria, i.e. K = 4z2δ/2/
2, where K is the number of effective samples and
zδ/2 is a critical value from the standard Normal distribution. Based on this connection,
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for instance, setting  = 0.124 and δ = 0.05 in the relative standard deviation FWSR is
equivalent to terminate the simulation when an ESS reaches K = 1000.
2.4 Simulation Study
We report the results of a simulation study undertaken to validate the model and estimation
procedure. The simulated dataset consists of a control group and five treatment groups.
The control group is simulated based on estimates from maximum likelihood estimation
(MLE) of a LMM on the control group of the experimental data. That is, denote Yi,t,99 as
the weight of mouse i ∈ {1, · · · , 297} from the control group (Diet No.99) taken at time
t ∈ {365, 395, 456, 517, 578, 639, 700, 760, 821, 882, 943, 1004, 1065, 1125, 1186}, we consider
the following LMM based on (2),
Yi,t,99 = α0 + α1t+ b0,i + b1,it+ i,t, i,t ∼ N(0, σ2), (12)
where α0 and α1 are the global intercept and slope, b0,i and b1,i are the subject specific
random effects, where bi = (b0,i, b1,i)
T ∼ N2(0, λ−1D I), and i,t is the measurement error.
Note that, as mentioned, the β’s in (2) are set to zero for the control group to serve as the
baseline model.
Parameter estimation of (12) was carried out using the lmer() function in the R package
lme4 (Bates et al., 2012). Notice time was rescaled using t = (t− 365)/365 prior to model
fitting. The MLE estimates are α = (45.49,−5.75)T and σ2 = 5.06, and we set λ−1D = 1.0.
Based on these estimates, we simulated 297 subjects from (12) as the control group.
We then simulated five treatment groups, each with 36 subjects, by adding βg,1’s to
(12), while keeping other settings the same as for the simulated control group,
Yi,t,g = α0 + α1t+ βg,1t+ b0,i + b1,it+ i,t, g = 1, · · · , 5, (13)
where βg,1 ∈ {−2.0,−0.5, 0.0, 0.5, 2.0} for each group. To be consistent with the experi-
mental settings, we artificially differentiate the slope of each treatment group by α1 + βg,1,
but maintained the same global intercept α0, since all mice were on the same diet at t = 0.
Note that, we did not incorporate the “die-off” mechanism from the experiment into the
simulation. Figure 1 shows the mean weight trajectories for this simulated dataset.
We followed the prior specification outlined in Section 2.1. The hyper-parameters d1, d2
were set to d1 = 0.001, d2 = 0.001 for the prior on λD to be vague. The hyper-parameters
for α|d3, d4 were set using estimates obtained from a fitted LMM on the simulated control
group. The prior inclusion probabilities for the treatment groups, i.e. pig, g = 1, · · · , 5, were
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Figure 1: Mean weight trajectories for the 5 treatment groups and the control group.
set to 0.5 for equal probability between inclusion and exclusion.
The component-wise Gibbs sampler was run as described in Section 2.2. The simulation
was terminated by the relative standard deviation FWSR with the tuning parameters  =
0.124 and δ = 0.05. It resulted in 16385 iterations with an effective sample size of at least
1000 for estimation of the posterior mean of all the parameters. The resulting MCMC
outputs show the chain is mixing well and centered near the true parameter values.
Table 1: Fixed-effects estimates for the simulated dataset. For MLE, mean and 95% con-
fidence interval (CI) are presented. For posterior inference, posterior mean, 95% credible
interval (CI) and marginal inclusion probability (standard error in the parenthesis) are
presented.
MLE Posterior
Parameter Truth Mean 95% CI Mean 95% CI Pr(γg,j = 1|y)
α0 45.50 45.570 (45.431, 45.570) 45.591 (45.484, 45.700)
α1 -5.75 -5.708 (-5.852, -5.565) -5.716 (-5.822, -5.612)
β1,1 -2.00 -2.130 (-2.546, -1.713) -2.126 (-2.562, -1.685) 0.992(6.10e-5)
β2,1 -0.50 -0.693 (-1.109, -0.276) -0.698 (-1.126, -0.267) 0.983(7.44e-4)
β3,1 0.00 -0.092 (-0.508, 0.325) -0.093 (-0.518, 0.341) 0.442(3.88e-3)
β4,1 0.50 0.708 (0.292, 1.125) 0.708 (0.283, 1.136) 0.987(5.74e-4)
β5,1 2.00 2.266 (1.849, 2.683) 2.268 (1.830, 2.695) 0.992(6.10e-5)
We compare our results to the estimates from the frequentist approach (see e.g. Fitzmau-
rice et al., 2004), as it is widely used to model such problems. Researchers often combine
LMM with certain model selection criteria, e.g. BIC, to determine which treatment are
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significantly differ from the control (see e.g. Spindler et al., 2013a). Table 1 contains the
posterior estimates from the proposed model, along with the MLE estimates from lme4
for the LMM. Despite that both approaches result in estimates close to the truth, our ap-
proach introduces the marginal inclusion probability for each treatment group that is vital
to straightforward interpretation and correct ranking of the significance of the treatment
effects. If a dichotomous decision is desired, setting a threshold to the suggested value of
0.8772, one would correctly classify Diet No.3 to be insignificant relative to the control.
The sensitivity to the prior inclusion probabilities was also evaluated by repeating the
simulation with pig’s set to ranging from 0.3 to 0.7. We found no difference in model ranking,
although the parameter estimates were slightly different. Other simulation settings showed
comparable parameter estimations between our method and the MLEs, and correctness in
model ranking, although the results are not shown here.
3 Application
In this section, we use the methodology detailed in Section 2 to analyze the mouse body
weight data (see Section 1.1). Out of the 56 treatment groups in the original study, we
limited our attention to 18 pre-screened treatments that the researchers are most interested
in, as well as the control diet (Diet No.99). The 18 groups exhibited altered weight trajecto-
ries, or were related chemically to groups that did. Since all the groups consumed the same
number of calories, weight trajectories are related to the disposition of dietary calories be-
tween body mass and metabolic energy, a key determinant of lifespan. For simplicity, we de-
note these 19 diets as G = {21, 22, 23, 24, 27, 28, 29, 34, 35, 39, 42, 43, 44, 45, 48, 53, 55, 63, 99}.
Similar to Section 2.4, the days on diet were rescaled prior to analysis. Figure 2a shows
the mean weight trajectories for the 19 diet groups. Note that the mean weight estimates
become unreliable as days on diet increases since mice died off in the process.
As previously pointed out, since the subjects were on the same diet at t = 0, it is
reasonable to assume the same intercept for all groups. The individual weight trajectories
suggest that, unlike the simulated dataset, a quadratic term is needed to characterize the
trajectories. Specifically, we re-write the LMM from (3) as
Yi,t,g = α0 + α1t+ α2t
2 + βg,1(γg,1)t+ βg,2(γg,2)t
2 + b0,i + b1,it+ b2,it
2 + i,t, g ∈ G. (14)
Given the quantity of the data, it is possible to propose more complex models with additional
polynomial terms. However, the additional terms complicate the model and the additional
coefficients are difficult to interpret scientifically. Hence, we considered the model at (14)
as our full model.
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Figure 2: Weight trajectories for the 18 treatment diets and the control diet.
Priors were specified as in the simulation study and γ99 was set to γ99 = (0, · · · , 0)T as
the baseline model. The Gibbs sampler was terminated by the relative standard deviation
FWSR with  = 0.124 and δ = 0.05, resulting in 115792 iterations with at least 1000
effective samples for estimation of posterior mean of the parameters related to fixed-effects
and variance components. The resulting MCMC outputs show the chain is mixing well
and indicate that the variation among subjects outweighs the variance of the measurement
errors.
Table 2 contains the posterior estimates from the proposed model, along with the MLE
estimates from the R package lme4 for the LMM. The results from the proposed method are
comparable to the MLEs in terms of point and interval estimates. However, the marginal
inclusion probability from the proposed method provides a direct measure of the signifi-
cance for each diet, which was unavailable in previous investigations using the frequentist
approach.
Figure 2b shows the fitted weight trajectories colored based on the magnitude of their
marginal inclusion probabilities. We can see that the treatment groups that have weight
trajectories similar to the control group are the ones with lower inclusion probabilities. It
shows that the marginal inclusion probability behaves well as a measure of the difference
between a treatment diet and the control diet. Moreover, we find the suggested threshold
0.8772 is a reasonable value to classify treatment diets into significantly/insignificantly
different from the control diet (see Figure 3a and Figure 3b).
As an example, we compare four diets (Diet No.21 - Diet No.24) that are supplemented
with 1.5, 2.5, 3.5, or 4.5 Nordihydroguaiaretic Acid (NDGA)/kg diet (Spindler et al., 2014c).
Figure 3c shows the mean weight trajectories and Figure 3d shows the fitted weight trajec-
tories for the 4 diets supplemented with NDGA and the control diet. We find that the fitted
trajectories correctly capture the characteristics of the mean weight trajectories for each
15
X X X
X
X
X
X
X
X
X
X
X
X
X
X
25
30
35
40
45
0.0 0.5 1.0 1.5 2.0
Rescaled Days on Diet
W
e
ig
ht
Group
Control
Diet No.34
Diet No.43
Diet No.44
Diet No.45
Diet No.53
Fitted Weight Trajectories (insignificant)
(a) Estimated weight trajectories for treat-
ment diets classified into insignificant and the
control diet.
X X X X
X
X
X
X
X
X
X
X
X
X
X
25
30
35
40
45
0.0 0.5 1.0 1.5 2.0
Rescaled Days on Diet
W
e
ig
ht
Group
Control
Diet No.21
Diet No.22
Diet No.23
Diet No.24
Diet No.27
Diet No.28
Diet No.29
Diet No.35
Diet No.39
Diet No.42
Diet No.48
Diet No.55
Diet No.63
Fitted Weight Trajectories (significant)
(b) Estimated weight trajectories for treat-
ment diets classified into significant and the
control diet.
XX X X
X
X
X
X X X X X X
X
X
X
25
30
35
40
45
0 1 2
Rescaled Days on Diet
W
e
ig
ht
Group
Control
Diet No.21
Diet No.22
Diet No.23
Diet No.24
Mean Weight Trajectories (NDGA diets)
(c) Mean weight trajectories for 4 NDGA
supplemented diets and the control diet.
X X
X
X
X
X
X
X
X
X
X
X
X
X
X
30
35
40
45
0.0 0.5 1.0 1.5 2.0
Rescaled Days on Diet
W
e
ig
ht
Group
Control
Diet No.21
Diet No.22
Diet No.23
Diet No.24
Fitted Weight Trajectories (NDGA diets)
(d) Estimated weight trajectories for 4
NDGA supplemented diets and the control
diet.
Figure 3: Analysis of the experimental dataset based on the proposed model.
diet, especially for the first half of the experiment when most mice were alive. These actual
and fitted weight trajectories indicate that NDGA produced a dose-responsive decrease in
body weight in the absence of a change in food consumption. These data suggest NDGA
may have extend mouse lifespan by decreasing calorie absorption, inducing a state of caloric
restriction, or by increasing metabolic rate. Further experiments will be required to resolve
these possibilities.
4 Discussion
This article proposes a novel method for Bayesian variable selection on LMM to compare
multiple treatments with a control. It is built upon a modification of the fractional prior
proposed by Smith and Kohn (1997) and a component-wise Gibbs sampler. It provides
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practitioners with a framework to incorporate prior knowledge of each treatment, as well
as an intuitive evaluation of its significance. This method is quite general and has a wide
range of potential applications in fields such as biology and medicine.
The proposed method is advantageous in that multiple treatments are compared to a
control group simultaneously. In addition, the Bayesian framework introduces marginal
inclusion probabilities for each group that allow direct measure of the significance of each
treatment, which is difficult using alternative frequentist approaches. Notice that, we in-
troduce a vector γg = (γg,0, · · · , γg,p−1)T in (3) as indicator instead of a single γg for each
group, because it allows a more in-depth comparison between two groups. In this paper,
the application on the experimental dataset provides new insights for researchers to group
and study the diets based on their levels of significance.
We emphasize careful posterior inference when using MCMC methodology. One major
challenge for practitioners is determining how long to run a simulation. While some simu-
lations are so complex that a fixed time approach is the only practical one, this is not so for
most experiments. We advocate the use of relative standard deviation FWSR (Flegal and
Gong, 2015; Gong and Flegal, 2015), since it is proved to be easy to use, theoretically valid
and superior to using convergence diagnostics as a stopping criteria (Flegal et al., 2008;
Jones et al., 2006).
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A Appendix
Full conditional posterior distributions are derived from (5), for i = 1, · · · , n, g = 1, · · · , G,
and j = 0, · · · , p−1. To calculate the full conditional posterior q(γg,j |α,γ−(g,j), b, σ2, y), we
integrate out β in (5) as Smith and Kohn (1996),
q(α, γ, b, σ2, λD|y) =
∫
q(α, β, γ, b, σ2, λD|y)dβ
∝
 G∏
g=1
[∏
i∈g
pi(bi|λD)
]
pi(γg)
pi(α)pi(λD)pi(σ2)
×
G∏
g=1
∫
βg
∏
i∈g
p(y i|α,βg, γg, bi, λD, σ2)pi(βg|α,γg, b, σ2)dβg
(15)
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To calculate (15), define φi = y i −Wiα − Zibi. For a given g, consider∫
βg
∏
i∈g
p(y i|α,βg, γg, bi, λD, σ2)pi(βg|α,γg, b, σ2)dβg
∝
∫
βg
∏
i∈g
σ−ni exp
{
− 1
2σ2
(
φi −Xi(γg)βg(γg)
)T(
φi −Xi(γg)βg(γg)
)}
× | 1
σ2
∑
i∈g
1
ni
XTi (γg)Xi(γg)|
1
2 × (2pi)− 12
∑p−1
j=0 γg,j
× exp
{
− 1
2
βg(γg)− (∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)φi
)T ( 1
σ2
∑
i∈g
XTi (γg)Xi(γg)
)
βg(γg)− (∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)φi
)}dβg
= σ−
∑
i∈g ni
( |∑i∈g 1niXTi (γg)Xi(γg)|
|∑i∈g(1 + 1ni )XTi (γg)Xi(γg)|
) 1
2
× exp
{
− 1
2σ2
G∑
g=1
[∑
i∈g
φTi φi +
(∑
i∈g
1
ni
XTi (γg)φi
)T(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)φi
)
−
(∑
i∈g
(1 +
1
ni
)XTi (γg)φi
)T(∑
i∈g
(1 +
1
ni
)XTi (γg)Xi(γg)
)−1(∑
i∈g
(1 +
1
ni
)XTi (γg)φi
)]}
Therefore, (15) is further simplified
= λ
np/2
D exp{−
λD
2
G∑
g=1
∑
i∈g
bTi bi}
G∏
g=1
p∏
j=1
pi
γg,j
g (1− pig)1−γg,j exp{−1
2
(α − d3)Td4(α − d3)}
× λd1−1D exp{−d2λD}
G∏
g=1
σ−
∑
i∈g ni
( |∑i∈g 1niXTi (γg)Xi(γg)|
|∑i∈g(1 + 1ni )XTi (γg)Xi(γg)|
) 1
2
× exp
{
− 1
2σ2
G∑
g=1
[∑
i∈g
φTi φi +
(∑
i∈g
1
ni
XTi (γg)φi
)T(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)φi
)
−
(∑
i∈g
(1 +
1
ni
)XTi (γg)φi
)T(∑
i∈g
(1 +
1
ni
)XTi (γg)Xi(γg)
)−1(∑
i∈g
(1 +
1
ni
)XTi (γg)φi
)]}
(16)
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Based on (16), the full posterior distribution is characterized by
q(γg,j |α,γ−(g,j), b, σ2, y) ∝ piγg,jg (1− pig)1−γg,j
( |∑i∈g 1niXTi (γg)Xi(γg)|
|∑i∈g(1 + 1ni )XTi (γg)Xi(γg)
) 1
2
× exp
{
− 1
2σ2
[∑
i∈g
φTi φi +
(∑
i∈g
1
ni
XTi (γg)φi
)T(∑
i∈g
1
ni
XTi (γg)Xi(γg)
)−1(∑
i∈g
1
ni
XTi (γg)φi
)
−
(∑
i∈g
(1 +
1
ni
)XTi (γg)φi
)T(∑
i∈g
(1 +
1
ni
)XTi (γg)Xi(γg)
)−1(∑
i∈g
(1 +
1
ni
)XTi (γg)φi
)]}
,
where γ−(g,j) = (γg,0, · · · , γg,j−1, γg,j+1, · · · , γg,p−1)T .
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Table 2: Fixed-effects estimates for the experimental dataset. For MLE, mean and 95%
confidence interval (CI) are presented. For posterior inference, posterior mean, 95% credible
interval (CI) and marginal inclusion probability (standard error in the parenthesis) are
presented.
MLE Posterior
Parameter Mean 95% CI Mean 95% CI Pr(γg,j = 1|y)
α0 44.879 (44.638, 45.120) 44.903 (44.720, 45.086)
α1 -4.124 (-4.864, -3.384) -3.687 (-4.134, -3.237)
α2 -0.992 (-1.444, -0.540) -1.718 (-2.076, -1.369)
β21,1 -3.671 (-6.637, -0.705) -3.800 (-6.202, -1.432) 0.991(2.13e-4)
β21,2 1.244 (-0.553, 3.041) 1.667 (-0.151, 3.475) 0.809(1.15e-3)
β22,1 -7.894 (-10.828, -4.959) -8.069 (-10.353, -5.789) 0.996(1.22e-5)
β22,2 4.429 (2.644, 6.214) 4.611 (2.780, 6.461) 0.996(8.63e-6)
β23,1 -4.467 (-7.282, -1.652) -4.902 (-6.995, -2.810) 0.996(1.73e-5)
β23,2 1.819 (0.203, 3.435) 2.352 (0.638, 4.046) 0.970(4.75e-4)
β24,1 -12.373 (-15.317, -9.428) -12.453 (-14.795, -10.103) 0.996(8.64e-6)
β24,2 5.349 (3.533, 7.165) 5.596 (3.752, 7.444) 0.996(8.64-e6)
β27,1 -6.643 (-8.694, -4.592) -5.135 (-6.671, -3.570) 0.996(8.64e-6)
β27,2 3.173 (1.948, 4.397) 3.098 (1.872, 4.344) 0.996(8.64e-6)
β28,1 2.717 (0.585, 4.849) 3.899 (2.227, 5.611) 0.997(1.50e-5)
β28,2 -0.969 (-2.273, 0.335) -1.047 (-2.423, 0.316) 0.747(1.27e-3)
β29,1 -13.462 (-15.574, -11.350) -12.333 (-13.946, -10.704) 0.996(8.64e-6)
β29,2 6.499 (5.195, 7.803) 6.432 (5.097, 7.751) 0.996(8.64e-6)
β34,1 -0.768 (-2.898, 1.363) -0.892 (-2.441, 0.638) 0.663(1.39e-3)
β34,2 0.351 (-1.002, 1.704) 0.022 (-1.315, 1.459) 0.592(1.44e-3)
β35,1 -1.552 (-3.607, 0.503) -2.355 (-3.911, -0.752) 0.983(3.33e-4)
β35,2 0.563 (-0.670, 1.796) 1.384 (0.140, 2.657) 0.920(7.83e-4)
β39,1 3.183 (0.955, 5.410) 2.699 (0.829, 4.532) 0.975(4.29e-4)
β39,2 -2.422 (-3.877, -0.967) -2.212 (-3.707, -0.659) 0.976(4.16e-4)
β42,1 3.625 (1.560, 5.689) 3.478 (1.874, 5.054) 0.996(2.86e-5)
β42,2 -2.047 (-3.298, -0.795) -1.686 (-2.953, -0.423) 0.963(5.28e-4)
β43,1 1.627 (-0.442, 3.697) 1.298 (-0.201, 2.902) 0.815(1.13e-3)
β43,2 -0.659 (-1.910, 0.591) -0.364 (-1.705, 0.929) 0.584(1.45e-3)
β44,1 -2.230 (-4.532, 0.068) -1.028 (-2.777, 0.626) 0.675(1.37e-3)
β44,2 0.853 (-0.626, 2.331) 0.274 (-1.195, 1.889) 0.549(1.46e-3)
β45,1 1.094 (-1.122, 3.310) 1.357 (-0.351, 3.196) 0.772(1.23e-3)
β45,2 -0.160 (-1.631, 1.310) -0.696 (-2.308, 0.875) 0.633(1.41e-3)
β48,1 4.118 (2.032, 6.204) 3.361 (1.695, 5.014) 0.996(6.29e-5)
β48,2 -2.268 (-3.541, -0.995) -1.728 (-3.020, -0.439) 0.960(5.48e-4)
β53,1 -1.138 (-3.242, 0.966) -1.381 (-2.955, 0.185) 0.813(1.14e-3)
β53,2 0.047 (-1.343, 1.249) 0.176 (-1.181, 1.574) 0.530(1.47e-3)
β55,1 -1.714 (-3.800, 0.372) -2.442 (-4.072, -0.812) 0.983(3.27e-4)
β55,2 0.695 (-0.584, 1.975) 1.356 (0.061, 2.658) 0.894(8.92e-4)
β63,1 -2.483 (-4.590, -0.376) 2.712 (1.052, 4.376) 0.991(2.07e-4)
β63,2 -1.367 (-2.678, -0.056) -1.305 (-2.580, 0.019) 0.863(1.00e-3)
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